X hits on this document

91 views

0 shares

0 downloads

0 comments

18 / 34

2136

CANCER

November 15, 2007 / Volume 110 / Number 10

TABLE 7 Incidence Rates and Rate Ratios of the Top 15 Cancers for American Indian/Alaska Native Males Compared With Non-Hispanic White Males by Indian Health Service Region, Contract Health Service Delivery Area Counties in Selected Areas in the United States, 1999–2004

U.S. (CHSDA counties)

Northern plains

Alaska

AI/AN

AI/AN:NHW

AI/AN

AI/AN:NHW

AI/AN

AI/AN:NHW

Prostate

1

104.0

Lung and bronchus

2

68.0

Colon and rectum

3

51.5

Kidney and renal pelvis

4

22.7

Urinary bladder

5

16.1

Non-Hodgkin lymphoma

6

14.9

Stomach

7

14.2

Oral cavity and pharynx

8

13.0

Liver and IBD

9

13.0

Leukemia

10

10.6

Pancreas

11

9.7

Esophagus

12

7.8

Myeloma

13

6.5

Melanoma of the skin

14

5.9

Larynx

15

5.3

Brain and ONS

16

5.0

Testis

17

4.0

Gallbladder

18

2.5

Cancer site or typea

Rank Ratec

All sitesb

406.9

95% CI

Rank Ratec

NHW ratec

RR

95% CI

Rank Ratec

NHW ratec

RR

0.72–0.75 0.64–0.70 0.73–0.82 0.80–0.91 1.20–1.43 0.34–0.43 0.57–0.72 1.48–1.88 0.70–0.88 1.79–2.27 0.57–0.73 0.66–0.88 0.76–1.05 0.86–1.22 0.18–0.25 0.64–0.94 0.48–0.67 0.52–0.71 2.65–4.99

1 2 3 4 5 8 9 6 7 11 13 10 14 12 15 17

611.4 164.6 115.5 79.8 29.7 27.6 20.2 16.7 21.5 21.0 13.7

9.9 14.1

7.1 10.3

5.6 5.1

542.5 160.0 86.7 62.0 17.4 39.4 22.8 8.4 15.3 5.4 16.4 12.0 9.3 6.5 19.0 6.5 8.4 6.5 0.6

1.13d 1.03 1.33 1.29 1.71 0.70 0.89 1.98d 1.40 3.89d 0.84 0.82 1.52 1.10 1.58 0.66 0.79

d d d d

1.06–1.20 0.91–1.16 1.15–1.54 1.08–1.52 1.33–2.15 0.49–0.95 0.61–1.24 1.33–2.80 0.98–1.92 2.71–5.37 0.58–1.17 0.50–1.26 0.95–2.28 0.60–1.82 0.88–2.56 0.37–1.11 0.51–1.24

3 1 2 5 6 11 4 8 9 12 7 10 13

543.3 82.1 116.5 98.5 28.6 23.0 13.2 34.6 20.9 17.2

8.4 21.4 13.2

6.1

569.0 179.9 84.8 61.4 18.7 47.3 26.3 7.7 15.3 8.2 15.2 9.6 9.3 6.1 16.4 5.2 8.1 7.1

0.95 0.46 1.37 1.60 1.53 0.49 0.50 4.46 1.36 2.09 0.55 2.22 1.43 0.86

NHW ratec

RR

553.5 154.7 87.6 60.4 17.4 41.5 23.2 8.5 16.6 6.4 16.4 12.6 8.7 6.3 27.4 6.7 8.7 6.6 0.7

0.74 0.67 0.78 0.85 1.31 0.39 0.64 1.67 0.78 2.02 0.65 0.77 0.90 1.03 0.21 0.78 0.57 0.61 3.70

d d d d d d d d d d d d

d d d d d

95% CI

0.88–1.03

d

0.37–0.56

d

1.14–1.64

d

1.31–1.95

d

1.06–2.16

d

0.31–0.71

d

0.32–0.76

d

2.89–6.84

0.92–1.97

d

1.19–3.46

d

0.31–0.95

d

1.37–3.47

0.80–2.39

0.50–1.48

Southern plains

Pacific coast

East

Cancer site or typea

AI/AN Rank Ratec

NHW ratec

AI/AN:NHW

RR

95% CI

AI/AN Rank Ratec

NHW ratec

AI/AN:NHW

RR

95% CI

AI/AN Rank Ratec

NHW ratec

RR

AI/AN:NHW 95% CI

Oral cavity and pharynx

7

18.5

18.3

1.01

0.82–1.23

Liver and IBD

11

11.1

6.1

1.81d

1.37–2.34

Prostate

1

156.9

146.6

1.07

Lung and bronchus

2

108.7

109.1

1.00

Colon and rectum

3

68.9

63.5

1.08

Kidney and renal pelvis

4

25.2

17.8

1.41

Urinary bladder

5

24.8

34.9

0.71

Non-Hodgkin lymphoma

6

23.5

22.1

1.06

Leukemia Pancreas Esophagus Myeloma Melanoma of the skin Larynx Brain and ONS Testis Gallbladder

568.2

549.3

12

10.2

7.3

8

17.2

9

12.3

14

8.5

15

8.3

10

11.6

13

9.1

16

8.1

17

3.5

16.3

1.06

13.0

0.95

7.8

1.10

5.8

1.41

20.4

0.57

7.8

1.17

8.8

0.92

All sitesb

Stomach

1.03

1.40d

d d

1.00–1.07

    • 0.99

      –1.15

    • 0.91

      –1.09

    • 0.97

      –1.21

    • 1.19

      –1.67

    • 0.58

      –0.85

    • 0.87

      –1.28

    • 1.05

      –1.83

5.6 0.7

Southwest

d d

    • 0.85

      –1.30

    • 0.72

      –1.22

    • 0.78

      –1.49

    • 1.01

      –1.92

    • 0.44

      –0.73

    • 0.86

      –1.55

    • 0.68

      –1.21

    • 0.43

      –0.91

0.63d

1 2 3 4 5 8 9 7 6 10 12 11 14 13 17 16 15

333.0 83.1 56.5 44.0 14.8 13.3 12.6 11.8 12.6 12.7 9.3 6.6 7.5 4.6 5.6 3.2 3.7 3.8

556.8 160.4 82.4 56.4 16.8 41.9 24.1 8.2 17.1 6.5 16.6 12.8 8.7 6.4 31.9 5.8 9.2 7.2 0.6

    • 0.60

      d

    • 0.52

      d

    • 0.69

      d

    • 0.78

      d

0.88

    • 0.32

      d

    • 0.52

      d

    • 1.43

      d

    • 0.74

      d

    • 1.94

      d

    • 0.56

      d

    • 0.52

      d

0.86 0.72

    • 0.18

      d

    • 0.56

      d

    • 0.40

      d

    • 0.53

      d

    • 0.57

      –0.63

    • 0.47

      –0.57

    • 0.60

      –0.78

    • 0.67

      –0.90

    • 0.70

      –1.10

    • 0.24

      –0.41

    • 0.40

      –0.67

    • 1.05

      –1.90

    • 0.58

      –0.93

    • 1.50

      –2.46

    • 0.41

      –0.74

    • 0.35

      –0.73

    • 0.60

      –1.18

    • 0.45

      –1.08

    • 0.12

      –0.26

    • 0.33

      –0.88

    • 0.26

      –0.60

    • 0.38

      –0.72

6

286.3

1

82.9

2

45.4

3

35.5

5

15.1

4

20.4

9.8

578.4 156.3 94.5 65.9 18.7 43.9 23.9 9.9 16.8 6.9 17.1 13.3 8.8 6.5 27.2 8.2 8.6 6.2 0.8

    • 0.50

      d

    • 0.53

      d

    • 0.48

      d

    • 0.54

      d

0.81 0.46d 0.58d

    • 0.44

      –0.55

    • 0.43

      –0.65

    • 0.36

      –0.63

    • 0.38

      –0.73

    • 0.48

      –1.27

    • 0.28

      –0.70

0.33–0.96

AI/AN

AI/AN:NHW

Cancer site or typea

Rank Ratec

NHW ratec

RR

95% CI

0.51

d

0.49

d

0.28

d

0.48

d

1.59

d

0.13

d

0.51

d

Prostate

1

67.0

136.7

Lung and bronchus

4

22.1

78.1

Colon and rectum

2

26.7

56.1

Kidney and renal pelvis

3

25.1

15.8

Urinary bladder

11

5.5

41.1

Non-Hodgkin lymphoma

7

10.4

20.5

(continued)

All sitesb

261.5

513.1

    • 0.49

      –0.54

    • 0.44

      –0.54

    • 0.24

      –0.34

    • 0.41

      –0.55

    • 1.35

      –1.85

    • 0.09

      –0.19

    • 0.40

      –0.64

Document info
Document views91
Page views91
Page last viewedFri Dec 09 13:58:42 UTC 2016
Pages34
Paragraphs3857
Words25693

Comments